Toggle menu

Allan MacRaild

Stroke Lead Research Nurse

Research Interests:
Stroke, Emergency Medicine, Global Health, Medicine of the Elderly, Patient Experience and Action Research
Qualifications:
Masters of Nursing in Clinical Research, BSc (Hons) Nursing Studies, Bachelor of Nursing (Adult), BA Acting Studies
Twitter:
@emerge_research
Allan MacRaild

Allan has worked been part of the EMERGE team for three years. He arrived following a Masters of Nursing in Clinical Research and with a clinical background in general surgery.

 

During his time with the team he has co-ordinated a range of different studies (4AT, PATCH-ED, RAMPP, No PAC, POP) and collaborated with RRG on The PRIOR Study. He has recently taken up the role of Stroke Lead Research Nurse leading a small team and a growing portfolio of acute stroke studies. The Stroke Research Group has a reputation for pioneering work in haemorrhagic strokes (RESTART, SoSTART), imaging studies, and multi-site trials (FOCUS, CLOTS) and collaborates widely with the international Stroke research community.

 

He has also been fortunate to work with the Global Emergency Medicine team and travelled to Zambia in Spring 2018 to volunteer on the Sachibondu project – providing education and support to aremote rural clinic transitioning to a small local hospital.

 

Allan is passionate about people and bridging the gap between research and clinical practice and continues to thrive and enjoy the diversity of projects and experiences available in his role

 

In a previous life, Allan trained as an actor and is always ready for his close-up…

 

 


Trials

Minimal Unit Pricing Study (MUP)

Assessing the impact of the Minimum Unit Pricing

Read more

Minimal Unit Pricing Study (MUP)

Assessing the impact of the Minimum Unit Pricing

MRI in Acute Stroke

Strokes caused by a clot are described as ischaemic. When patients experience ischaemic strokes they may be eligible for “clot busting” therapy (thrombolysis). Currently thrombolysis has been shown to improve patient outcome after a stroke if administered within the first 4.5 hours after stroke onset. Up to 25% of patients wake up with symptoms of a stroke. This means they have an unknown onset time for their stroke (so called ‘wake up strokes’). With no known onset time, they are ineligible for thrombolysis. This study will investigate how we might determine stroke onset time.

Read more

MRI in Acute Stroke

The Prior Study

This study will investigate how we can help treat patients suffering from shock by the targeted use of specific fluids and medications. Shock is an acute medical condition in which the organs and tissues of the body are not receiving an adequate flow of blood. It is associated with a fall in blood pressure, a build-up in waste products and can result in serious organ damage and even death. We hope to improve our ability to treat shock by evaluating fluid management from the blood samples of a group of healthy volunteers.

Read more

The Prior Study

Calculating Osmotic Pressure in Healthy Patients

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

Read more

ATTEST2

Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)

HighSTEACS Bioresource

Evaluating the kinetics of cardiac biomarkers after ST-segment Elevation myocardial infarction

Read more

HighSTEACS Bioresource

NoPac

Patients commonly present to the Emergency Department with epistaxsis (nose bleed). Standard first aid measures such as applying pressure can often stem bleeding however in more severe cases of epistaxsis further treatment is required.

Read more

NoPac

Novel Use of Tranexamic Acid to Reduce the Need for Nasal Packing

RAMPP trial

Intervention
1. Ambulatory Device, Rocket Pleural vent insertion
2. Standard Treatment, Aspiration +/- chest drain
Primary Outcome Measures
To assess whether use of an ambulatory device (Rocket Pleural Vent) and treatment strategy reduces hospital stay. Total length of stay in hospital up to 30 days post randomisation. Up to 30 days post randomisation.

Read more

RAMPP trial

RAMPP trial - Randomised Controlled Trial: Pleural vent (rocket) V standard care in Primary Spontaneous Pnuemothorax

SALI Study

This is a study looking at incidence and risk factors for poor ankle functional recovery, and the development and progression of post-traumatic ankle osteoarthritis after significant ankle ligament injury.

Read more

SALI Study

SALI study - Significant Ankle Ligament Injury

COPS

This study contributes to the work of Dr Frank Prior who is developing a tool to be used in the treatment of shock.
It is known that shock creates a set of internal conditions that affect vasculature and that these conditions can vary over time and are dependent on the type of shock. This tool reveals the condition of the vasculature and therefore informs which fluid and drugs are best advised for that patient at that time.

Read more

COPS

Calculating Osmotic Pressure in Healthy Patients (COPs)

4AT

Determining the diagnostic accuracy of the 4AT for delirium versus the reference standard of a DSM-IV diagnosis

Read more

4AT

The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients

PATCH-ED

Diagnostic yield of an ambulatory patch monitor in Emergency Department syncope patients.

Read more

PATCH-ED

Diagnostic yield of an ambulatory patch monitor in ED

Related news

The Prior Study

The Prior Study

19 Jul 2017 | Allan MacRaild

EMERGE and RRG are undertaking a preliminary study into the principles of fluid exchange within the body.

Read more
The Beats That My Heart Skipped

The Beats That My Heart Skipped

23 Jan 2017 | Allan MacRaild

Heartbeats provide the rhythm of life. Interruptions to this rhythm are more likely to lead to a loss of consciousness than just a loss of spark. Rob Hannigan (pictured with Senior Research Nurse Allan MacRaild) took part in the PATCH-ED trial in 2016 following a number of unexplained blackouts. The results of his PATCH highlighted some dangerous arrhythmias including 24 seconds when his heart stopped beating entirely. Six months after his participation in the PATCH-ED trial, Rob met up with Allan to share his experiences.

Read more
4AT team attends British Geriatric Society conference

4AT team attends British Geriatric Society conference

5 Nov 2015 | Allan MacRaild

Emerge sent two research nurses to the British Geriatric Society (BGS) conference. Jill Steven and Allan MacRaild are recruiting to a study entitled The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients. This study is a first collaboration between Emerge and Medicine of the Elderly with this study being led by Professor Alasdair MacLullich.

Read more
A study to assess a tool to diagnose Delirium